Drägerwerk stock gains in TecDAX as investors watch recent price strength

Published on 09/15/2026 at 21:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock is trading at 114.20 euros on Xetra on September 15, 2026, up 1.60 percent at the start of TecDAX and SDAX trading. The shares have delivered a year to date performance of 29.05 percent, underscoring the recent momentum in the medical technology group.

Moderne Intensivstation mit Beatmungsgerät und Patientenmonitoring in klinischer Umgebung — Drägerwerk AG & Co. KGaA zeigt moderne Intensivstation mit Beatmungsgeräten und Patientenmonitoring DE0005550636, Illustration mit AI erstellt.

Drägerwerk AG & Co. KGaA stock (ISIN DE0005550636) is trading higher on Xetra, with the shares quoted at 114.20 euros in early Frankfurt trading on September 15, 2026, corresponding to a gain of 1.60 percent versus the prior Xetra close per price indications from finanzen.ch.

Drägerwerk stock starts the session firmer

According to finanzen.ch on September 15, 2026, Drägerwerk is among the stronger names in the TecDAX at the start of trading, with the stock up 1.60 percent at 114.20 euros based on Xetra data for the early session.

In a parallel report on the broader SDAX, finanzen.ch also lists Drägerwerk among the gainers, again citing a 1.60 percent increase to 114.20 euros in the early phase of the September 15, 2026 Frankfurt session, which places the shares in the group of top-performing small caps at the open.

Recent performance and index context

A company overview on MarketScreener indicates that Drägerwerk shares have achieved a year to date performance of 29.05 percent as of September 14, 2026, highlighting a notable price appreciation over the course of 2026 compared with the level at the start of the year.

In the same data overview, MarketScreener reports a last close price of 112.40 euros for Drägerwerk stock, which implies that the early Xetra quote of 114.20 euros on September 15, 2026 stands about 1.80 euros, or roughly 1.60 percent, above that most recent closing level, underlining the firm tone in the shares at the beginning of the new session.

While the TecDAX 10 CAPPED index itself is only slightly higher, with tagesschau.de showing a level of 3,783.80 points on September 15, 2026, up 0.15 percent on the day, Drägerwerk's gain of 1.60 percent at the open means the stock is outperforming the broader technology benchmark during the early part of the session.

Stock remains supported by recent gains

On a medium term view, the combination of a 29.05 percent year to date increase and the current 114.20 euro quote positions Drägerwerk stock well above its start of year level, even though the shares are trading modestly above the recent closing price of 112.40 euros recorded in the latest completed Xetra session referenced by MarketScreener.

For investors, the fact that Drägerwerk is simultaneously cited as a top gainer in both TecDAX and SDAX reports on September 15, 2026 suggests that the medical technology group continues to attract buying interest despite a generally lighter tone in the broader Frankfurt market at the start of trading.

Drägerwerk stock price and key data

Based on Xetra indications cited by finanzen.ch for September 15, 2026, Drägerwerk stock is trading at 114.20 euros in the early Frankfurt session, up 1.60 percent from the prior close of 112.40 euros, with Xetra as the primary trading venue for the shares.